The renaissance of centrally acting antihypertensive drugs

Journal of Hypertension, Supplement

Volumn 17, Issue 3, 1999, Pages

  Van Zwieten, Pieter A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

2 adrenoceptors; Centrally acting antihypertensives; Clonidine; Imidazoline (i1) receptors; Moxonidine; Rilmenidine; Sympathetic system

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR;

ADRENERGIC SYSTEM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ADRENERGIC ALPHA-AGONISTS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; IMIDAZOLES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS;

EID: 0033175677     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Julius S. Sympathetic overactivity and the pathophysiology of coronary risk in hypertension. Cardiovasc Risk Factors 1995; 5(suppl 1):2-10.
2. Van Zwieten PA Hendriks MGC, Pfaffendorf M, Bruning TA Chang PC. The parasympathetic system and its muscarinic receptors in hypertensive disease. J Hypertens 1995; 13:1079-1090.
3. Van Zwieten PA Chalmers JR Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovasc Drug Ther 1994; 8:787-799.